ELAINE R. WEDRAL - Corporate Board Profile

BALCHEM CORP

Filing Date	Source Excerpt
2006-04-28	Dr. Elaine R. Wedral, age 62, has been a director since October 2003. ... The current members of the Compensation Committee are Messrs. McMillan, Mitchell, Dr. Televantos (Chair) and Dr. Wedral, each of whom are independent directors. ... The current members of the Corporate Governance & Nominating Committee are Messrs. Ammidon and Mitchell and Drs. Televantos and Wedral (Chair), all of whom are "independent" under AMEX listing standards. ... For 2005, the Company paid each of its directors, other than Mr. Rossi, an annual fee of $13,000 and $4,000 for each Board meeting attended. For fiscal 2005, the Company also paid to each of its directors serving on Committees the following fees, plus expenses, for each Committee meeting attended: Chairman of the Audit Committee, $2,500; Chairman of the Compensation Committee, $2,000; chairman of all other Committees, $1,500; all other Committee members, $1,000. The Lead Director is paid an additional $5,000 per year.
2007-04-27	Dr. Elaine R. Wedral, age 63, has been a Director since October 2003. Dr. Wedral is retired. ... The current members of the Compensation Committee are Messrs. McMillan, Mitchell, Dr. Televantos (Chair) and Dr. Wedral, each of whom are independent directors. ... The current members of the Corporate Governance & Nominating Committee are Messrs. Ammidon and Mitchell and Drs. Televantos and Wedral (Chair). ... The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company's directors (other than Mr. Rossi, whose compensation is set forth in the Summary Compensation Table above) during the fiscal year ended December 31, 2006. ... Elaine Wedral $42,500 $115,560 - $158,060
2008-04-25	Dr. Elaine R. Wedral, age 64, has been a Director of the Company since October 2003. ... The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. McMillan and Mitchell, and Dr. Wedral, each of whom are independent directors. ... The current members of the Corporate Governance & Nominating Committee are Dr. Wedral (Chair), Messrs. Ammidon and Mitchell and Dr. Televantos.
2009-04-28	Dr. Elaine R. Wedral, age 65, has been a Director of the Company since October 2003...The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. McMillan and Mitchell, and Dr. Wedral...The current members of the Corporate Governance & Nominating Committee are Dr. Wedral (Chair), Messrs. Premdas and Mitchell and Dr. Televantos...The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company's directors (other than Mr. Rossi, whose compensation is set forth in the Summary Compensation Table above) during the fiscal year ended December 31, 2008. Elaine Wedral $54,000 Fees Earned or Paid in Cash, $109,863 Stock Awards, Total $163,863.
2010-04-30	Dr. Elaine R. Wedral, age 66, has been a director of the Company since October 2003. Dr. Wedral is retired. Currently, she serves as the President of the International Life Sciences Institute in North America, which position she has held since January 2008. She was President of Nestle9 R&D Center, Inc. in New Milford, Connecticut and Head of Nestle9 Food Service Systems worldwide from 1999 to 2005. Prior to that, she held a variety of technical positions at Nestle9. Dr. Wedral holds 34 patents in food processing, food nutrition and ingredient areas, and is on the editorial board of Food Processing Magazine.
2011-04-28	Dr. Elaine R. Wedral, age 67, a Class 1 director whose current term expires 2013, has been a director of the Company since October 2003. The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. Fischer, McMillan, and Dr. Wedral. The current members of the Corporate Governance and Nominating Committee are Dr. Wedral (Chair), Messrs. Premdas, Coombs and Dr. Televantos. The Company pays each of its directors, other than Mr. Rossi, an annual retainer of $24,000 and $4,000 for each Board meeting attended, plus expenses. The Lead Director, Chairman of the Audit Committee and Chairman of the Compensation Committee are paid an additional $8,000 annual retainer fee. The Chairman of the Corporate Governance and Nominating Committee is paid an additional $6,000 annual retainer fee. The Company also pays to each of its directors serving on Committees a fee of $1,000, plus expenses, for each Committee meeting attended. The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company’s directors (other than Mr. Rossi) during the fiscal year ended December 31, 2010. Elaine Wedral Fees Earned or Paid in Cash ($) 57,000 Stock Awards ($) 100,016 All Other Compensation ($) – Total ($) 160,264.
2012-04-27	Dr. Elaine R. Wedral, age 68, a Class 1 director whose current term expires 2013, has been a director of the Company since October 2003. ... Dr. Wedral is retired. ... The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. Fischer, McMillan, and Dr. Wedral. ... The current members of the Corporate Governance and Nominating Committee are Dr. Wedral (Chair), Messrs. Premdas, Coombs and Dr. Televantos. ... Elaine Wedral: Fees Earned or Paid in Cash $56,000, Stock Awards $100,033, Total $156,033.